Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034702620> ?p ?o ?g. }
- W2034702620 endingPage "22" @default.
- W2034702620 startingPage "22" @default.
- W2034702620 abstract "<b>Objectives</b> : The aim of present study is to analyze the intermediate and long-term follow up results of percutaneous closure of fossa ovalis atrial septal defect (ASD) with Amplatzer septal occluder (ASO) in a large cohort of patients including children and adults.<br><b>Methods</b> : Between May 1998 and July 2008, 529 patients (age group 2-77 years, median 28 years) underwent successful device closure with an ASO at single tertiary referral cardiac center in India.. This was out of an attempted 543 cases. The procedure was carried out in catheterization laboratory under transesophageal echocardiographic and fluoroscopy guidance. The mean size of ASD was 20 mm (7-40 mm) while size of septal occluder was 10-40 mm (mean 24 mm). Two devices were deployed in four patients. Three patients developed transitory pulmonary edema in immediate postprocedure period requiring ICU care for 48 hrs. All patients were advised for Aspirin (3-5 mg/kg, maximum 150 mg) once daily for 6 months. In patients with device 30 mm or larger, Clopidogril ( 75 mg once daily) was given for 3 months in addition to Aspirin. Clinical evaluation, echocardiogram were done on 3 months, 6 months and then at 1, 3, 5, 7 and 10 years of follow up. Transesophageal echocardiography (TEE) was performed in case of any doubt on clinical evaluation or on transthoracic echocardiography (n=10). <br><b>Results</b> : Followup data is available for 496 patients (93.7%). Followup period is from 12 months to 120 months (median 56 months). On followup, device was in position in all patients, no residual shunt and no evidence of thrombosis. Interventricular septal motion normalized on day of procedure in 89% patients, in 6% over 3 months while flat septal motion persisted in 5% (n=25, all in age group > 40 years) of cases, though right ventricular dilatation persisted in 10% (n=50, age more than 40 years) of patients. Symptom-free survival was 96.7 % (480/496) in patients who came for followup. Only one 68 year old patient with preexistent tricuspid regurgitation developed congestive heart failure, and one patient (58 years old) had a history of hemiparesis after 1 year of device on telephonic interview. Ten patients were in atrial fibrillation (AF) before the procedure and remained in AF on followup.<br><b>Conclusions</b> : Our study showed that percutaneous closure of fossa ovalis ASD is a safe and effective procedure on intermediate and long-term followup in both the children as well as adults.both. Technical factors during the procedure and proper follow up are important. Our single centre intermediate and long term experience in a large number of patients support the use of device closure as an alternative to surgery." @default.
- W2034702620 created "2016-06-24" @default.
- W2034702620 creator A5018918357 @default.
- W2034702620 creator A5060169456 @default.
- W2034702620 creator A5065097825 @default.
- W2034702620 creator A5065866939 @default.
- W2034702620 date "2011-01-01" @default.
- W2034702620 modified "2023-10-16" @default.
- W2034702620 title "Intermediate and long-term followup of percutaneous device closure of fossa ovalis atrial septal defect by the Amplatzer septal occluder in a cohort of 529 patients" @default.
- W2034702620 cites W115745132 @default.
- W2034702620 cites W1580143606 @default.
- W2034702620 cites W1978203902 @default.
- W2034702620 cites W1994448176 @default.
- W2034702620 cites W2007646298 @default.
- W2034702620 cites W2008564184 @default.
- W2034702620 cites W2011412540 @default.
- W2034702620 cites W2011902344 @default.
- W2034702620 cites W2016642318 @default.
- W2034702620 cites W2020465567 @default.
- W2034702620 cites W2036383877 @default.
- W2034702620 cites W2043288177 @default.
- W2034702620 cites W2057658861 @default.
- W2034702620 cites W2070062046 @default.
- W2034702620 cites W2073426595 @default.
- W2034702620 cites W2092711678 @default.
- W2034702620 cites W2095404550 @default.
- W2034702620 cites W2106985215 @default.
- W2034702620 cites W2122619298 @default.
- W2034702620 cites W2132217029 @default.
- W2034702620 cites W2136606646 @default.
- W2034702620 cites W2141217644 @default.
- W2034702620 cites W2159096857 @default.
- W2034702620 cites W2166636369 @default.
- W2034702620 cites W2171912681 @default.
- W2034702620 cites W2299187555 @default.
- W2034702620 cites W235614 @default.
- W2034702620 cites W2024084729 @default.
- W2034702620 doi "https://doi.org/10.4103/0974-2069.79618" @default.
- W2034702620 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3104526" @default.
- W2034702620 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21677800" @default.
- W2034702620 hasPublicationYear "2011" @default.
- W2034702620 type Work @default.
- W2034702620 sameAs 2034702620 @default.
- W2034702620 citedByCount "24" @default.
- W2034702620 countsByYear W20347026202012 @default.
- W2034702620 countsByYear W20347026202013 @default.
- W2034702620 countsByYear W20347026202015 @default.
- W2034702620 countsByYear W20347026202016 @default.
- W2034702620 countsByYear W20347026202017 @default.
- W2034702620 countsByYear W20347026202018 @default.
- W2034702620 countsByYear W20347026202019 @default.
- W2034702620 countsByYear W20347026202020 @default.
- W2034702620 countsByYear W20347026202021 @default.
- W2034702620 countsByYear W20347026202022 @default.
- W2034702620 crossrefType "journal-article" @default.
- W2034702620 hasAuthorship W2034702620A5018918357 @default.
- W2034702620 hasAuthorship W2034702620A5060169456 @default.
- W2034702620 hasAuthorship W2034702620A5065097825 @default.
- W2034702620 hasAuthorship W2034702620A5065866939 @default.
- W2034702620 hasBestOaLocation W20347026201 @default.
- W2034702620 hasConcept C126322002 @default.
- W2034702620 hasConcept C141071460 @default.
- W2034702620 hasConcept C164705383 @default.
- W2034702620 hasConcept C2776804676 @default.
- W2034702620 hasConcept C2776805002 @default.
- W2034702620 hasConcept C2776893843 @default.
- W2034702620 hasConcept C2777010224 @default.
- W2034702620 hasConcept C2777385415 @default.
- W2034702620 hasConcept C2777615863 @default.
- W2034702620 hasConcept C2779161974 @default.
- W2034702620 hasConcept C2780073493 @default.
- W2034702620 hasConcept C2780813298 @default.
- W2034702620 hasConcept C71924100 @default.
- W2034702620 hasConcept C72563966 @default.
- W2034702620 hasConceptScore W2034702620C126322002 @default.
- W2034702620 hasConceptScore W2034702620C141071460 @default.
- W2034702620 hasConceptScore W2034702620C164705383 @default.
- W2034702620 hasConceptScore W2034702620C2776804676 @default.
- W2034702620 hasConceptScore W2034702620C2776805002 @default.
- W2034702620 hasConceptScore W2034702620C2776893843 @default.
- W2034702620 hasConceptScore W2034702620C2777010224 @default.
- W2034702620 hasConceptScore W2034702620C2777385415 @default.
- W2034702620 hasConceptScore W2034702620C2777615863 @default.
- W2034702620 hasConceptScore W2034702620C2779161974 @default.
- W2034702620 hasConceptScore W2034702620C2780073493 @default.
- W2034702620 hasConceptScore W2034702620C2780813298 @default.
- W2034702620 hasConceptScore W2034702620C71924100 @default.
- W2034702620 hasConceptScore W2034702620C72563966 @default.
- W2034702620 hasIssue "1" @default.
- W2034702620 hasLocation W20347026201 @default.
- W2034702620 hasLocation W20347026202 @default.
- W2034702620 hasLocation W20347026203 @default.
- W2034702620 hasLocation W20347026204 @default.
- W2034702620 hasOpenAccess W2034702620 @default.
- W2034702620 hasPrimaryLocation W20347026201 @default.
- W2034702620 hasRelatedWork W1517714144 @default.
- W2034702620 hasRelatedWork W1548201843 @default.
- W2034702620 hasRelatedWork W1568037865 @default.